<p>(A) Three-dimensional representation of the interactions of compound 13 and target protein. (B) Pharmacophore mapping of hit compound 13. (C) Three-dimensional representation of the interactions of compound 14 and target protein. (D) Pharmacophore mapping of hit compound 14.</p
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
<p>(A) Typical example of the output of docking done by VINA showing 9 top scoring docking solutions...
<p>(A) 2D molecular docking modeling of compound <b>C6</b> with 3PSD. (B) 3D model of the interactio...
<p>Detailed view of the docking poses of drug [(A, B) PYZ and (C, D) DCS]- Aβ-42 interaction.</p
<p>Active site residues are shown in stick form. PD00519 and compound 1 are color-coded: green – PD0...
<p>The docking conformation of compound 1 in the training set (green) was compared with that of the ...
<p>Detailed view of the docking poses of drug [(A, B) PYZ and (C,D) DCS]-HEWL interaction.</p
Proteins (e.g., enzymes, receptors, hormones, antibodies, transporter proteins, etc.) seldom act alo...
(A) Docking results of beta sitosterol targeting AKT2; (B) Docking results of beta sitosterol target...
The results of molecular docking pose interactions between compounds and proteins.</p
Docking simulation results of 4 compounds with docking score energy and interaction with amino acids...
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
<p>A) Docking pose of etoposide relative to Top2α. Protein backbone and surface shown in cyan. Two r...
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
<p>(A) Typical example of the output of docking done by VINA showing 9 top scoring docking solutions...
<p>(A) 2D molecular docking modeling of compound <b>C6</b> with 3PSD. (B) 3D model of the interactio...
<p>Detailed view of the docking poses of drug [(A, B) PYZ and (C, D) DCS]- Aβ-42 interaction.</p
<p>Active site residues are shown in stick form. PD00519 and compound 1 are color-coded: green – PD0...
<p>The docking conformation of compound 1 in the training set (green) was compared with that of the ...
<p>Detailed view of the docking poses of drug [(A, B) PYZ and (C,D) DCS]-HEWL interaction.</p
Proteins (e.g., enzymes, receptors, hormones, antibodies, transporter proteins, etc.) seldom act alo...
(A) Docking results of beta sitosterol targeting AKT2; (B) Docking results of beta sitosterol target...
The results of molecular docking pose interactions between compounds and proteins.</p
Docking simulation results of 4 compounds with docking score energy and interaction with amino acids...
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
<p>A) Docking pose of etoposide relative to Top2α. Protein backbone and surface shown in cyan. Two r...
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
In view of the increasing interest both in inhibitors of protein-protein interactions and in protein...
<p>(A) Typical example of the output of docking done by VINA showing 9 top scoring docking solutions...
DOI
Add to ORKG